Accelerate Diagnostics Inc expected to post a loss of 30  cents a share - Earnings Preview

Accelerate Diagnostics

14/05/2022 24:37

* Accelerate Diagnostics Inc  AXDX.OQ   AXDX.O  is expected
to show a rise in quarterly revenue when it reports  results on
May 16. 
    * The Tucson Arizona-based  company is expected to report  a
17.2% increase in revenue to $2.952 million from $2.52 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Accelerate
Diagnostics
Inc is for a loss of 30 cents per share. For the same quarter
last year, the company reported a loss of 41 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $5​, above​ its last closing price of $0.69.
​​​

This summary was machine generated May 13 at 23:37 GMT.  All
figures in US dollars  unless otherwise stated